▶︎ Journal of Atherosclerosis and Thrombosis
——————————
Editorials
——————————-
The Ratio of Circulating Eicosapentaenoic Acid to Arachidonic Acid Ratio in the Community-Dwelling Japanese Population
Naoko Miyagawa, J Atheroscler Thromb, 2023; 30: 587-588.
——————————
Original Articles
——————————
Changes in the Eicosapentaenoic Acid to Arachidonic Acid Ratio in Serum over 10 Years in a Japanese Community: The Hisayama Study
Takanori Honda, et al., J Atheroscler Thromb, 2023; 30: 589-600.
Elevated hs-CRP and Symptomatic Intracranial/Extracranial Artery Stenosis Predict Stroke Recurrence after Acute Ischemic Stroke or TIA
Shiyu Li, et al., J Atheroscler Thromb, 2023; 30: 601-610.
Paradoxical Long-Term Impact Between Serum Apolipoprotein E and High-Density Lipoprotein Cholesterol in Patients Undergoing Percutaneous Coronary Intervention
Tatsuya Fukase, et al., J Atheroscler Thromb, 2023; 30: 611-623.
Significant Impact of Age on Mortality and Non-significant Impact of Age on Thrombosis and Major Bleeding in Patients with COVID-19: From the CLOT-COVID Study
Yugo Yamashita, et al., J Atheroscler Thromb, 2023; 30: 624-635.
Relevance of Carotid Reocclusion in Tandem Lesions
Elena Zapata-Arriaza, et al., J Atheroscler Thromb, 2023; 30: 636-648.
Clinical Outcomes and Unique Restenosis of Calcified Nodule in Heavily Calcified Coronary Artery
Hiroyuki Jinnouchi, et al., J Atheroscler Thromb, 2023; 30: 649-662.
Impact of Guideline-Directed Medical Therapy on 10-Year Mortality after Revascularization for Patients with Chronic Limb-Threatening Ischemia
Yosuke Hata, et al., J Atheroscler Thromb, 2023; 30: 663-674.
Sex Difference in the Impact of Dual Antiplatelet Therapy using Cilostazol for Secondary Stroke Prevention: A Sub-Analysis of CSPS.com
Haruhiko Hoshino, et al., J Atheroscler Thromb, 2023; 30: 675-683.
The Association of Remnant Cholesterol with Endothelial Dysfunction and Subclinical Atherosclerosis in a Check-Up Population in China
Ping-ting Yang, et al., J Atheroscler Thromb, 2023; 30: 684-697.
——————————
Erratum
——————————
Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study
Akihiro Nakamura, et al., J Atheroscler Thromb, 2023; 30: 698-699.